Stonepine Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-509,356
Closed -$1.02M 31
2019
Q3
$1.02M Buy
+509,356
New +$1.03M 0.99% 18
2019
Q1
Sell
-424,101
Closed -$1.06M 35
2018
Q4
$1.06M Sell
424,101
-474,056
-53% -$1.58M 0.93% 17
2018
Q3
$3.61M Sell
898,157
-1,031,865
-53% -$4.55M 2.11% 14
2018
Q2
$7.29M Sell
1,930,022
-1,311,528
-40% -$3.42M 4.43% 8
2018
Q1
$7.52M Buy
3,241,550
+45,858
+1% +$72.5K 4.03% 9
2017
Q4
$4.95M Buy
3,195,692
+328,907
+11% +$528K 2.97% 13
2017
Q3
$6.11M Buy
2,866,785
+1,271,236
+80% +$4.32M 3.6% 12
2017
Q2
$7.21M Sell
1,595,549
-1,161,711
-42% -$4.21M 3.89% 12
2017
Q1
$8.3M Sell
2,757,260
-401,556
-13% -$1.18M 4.68% 9
2016
Q4
$8.72M Buy
3,158,816
+1,240,094
+65% +$3.55M 5.19% 8
2016
Q3
$6.01M Buy
+1,918,722
New +$7M 4.9% 7

Other funds holding CORV